ÂÜÀòÂÒÂ×

Derek Underwood is a seasoned professional in the private equity and biotechnology sectors, currently serving as Principal at Cimbal Capital Group since May 2024 and as an Advisor for ImmuneAGE Bio and Q Bio. With a background that includes roles as Strategic Advisor at Mitrix.bio and Tau Ventures, and Investor at Endiatx, Derek has a strong track record in technology and health innovation. Previously, Derek was the CEO and COO of SensOmics Inc and spent seven years at INVISTA as Global Product & Marketing Manager, where significant revenue growth and strategic initiatives were achieved. Derek's educational credentials include an MBA in Finance and Entrepreneurship and a dual BS in Chemical Engineering and Biomedical Engineering from Carnegie Mellon University.